USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

EISAI R&；D MANAGEMENT CO.; LTD.

发明人:

Bruce A. LITTLEFIELD,Gary HENDLER

申请号：

US16318198

公开号：

US20190282541A1

申请日:

2017.07.20

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The invention features methods for treating and preventing cancer (e.g., a hormone sensitive cancer) in a patient in need thereof by administering eribulin (e.g., eribulin mesylate) in combination with a histone deacetylase (HDAC) inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/